In this issue:
Growth rates of genetically defined renal tumours
Genomic analysis of translocation RCC and drivers of disease progression
Deferred cytoreductive nephrectomy following presurgical VEGFR-TKIs in primary metastatic ccRCC
Non-visible haematuria for the detection of bladder, upper tract, and kidney cancer
Complete metastasectomy of RCC in the post-cytokine era
Gender-based differences in distress symptoms in patients with non-metastatic RCC
A gene risk score system and a nomogram survival model for predicting the prognosis of ccRCC
Histotype predicts the rate of lymph node invasion at nephrectomy in nonmetastatic RCC
MAPT as a prognostic marker in ccRCC
PT2385, a first-in-class HIF-2 inhibitor, in patients with ccRCC
Please login below to download this issue (PDF)